Asia
Lingrui Pharmaceutical H1 Profit Up 4.4%; Shares Fall 9%
Henan Lingrui Pharmaceutical (SHA:600285) posted first-half attributable net profit of 495.1 million yuan, up 4.4% from 474.4 million yuan the previous year.Earnings per share climbed to 0.871 yuan from 0.834 yuan, according to a half-year report filed on the Shanghai bourse.Operating revenue climbed 2.3% year over year to 2.15 billion yuan from 2.10 billion yuan.Shares of the pharmaceutical company fell 9% in recent trade.
SHA:600285
